Agentic AI for Immune-Related Adverse Event Detection in Cancer Immunotherapy – Oncodaily

Researchers are developing agentic AI systems designed to detect immune-related adverse events (irAEs) in cancer immunotherapy patients. The technology aims to improve monitoring and early identification of potentially serious side effects associated with cancer treatments. This advancement could enhance patient safety and treatment outcomes in oncology care.

Read Full Article →